Production (Stage)
Atai Life Sciences N.V.
ATAI
$2.32
$0.010.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.16% | -48.21% | 54.14% | -114.55% | -46.04% |
| Total Depreciation and Amortization | -4.00% | 171.08% | 1.22% | -1.20% | -17.82% |
| Total Amortization of Deferred Charges | -20.74% | 43.51% | 33.67% | 0.00% | -1.01% |
| Total Other Non-Cash Items | -45.56% | 87.31% | -74.33% | 323.76% | 237.90% |
| Change in Net Operating Assets | 57.15% | -33.12% | -205.24% | 157.44% | -290.14% |
| Cash from Operations | 26.57% | -25.61% | -19.18% | 28.11% | -2.78% |
| Capital Expenditure | -16,866.67% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -261.04% | -75.01% | 52.38% | 42.11% | 1,446.36% |
| Cash from Investing | -267.90% | -73.59% | 52.38% | 42.11% | 1,493.80% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 38,970.78% | 180.00% | -83.13% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | 38,604.55% | -96.85% | 1,401.23% | -- | -- |
| Foreign Exchange rate Adjustments | -73.98% | -48.10% | 259.09% | 203.13% | 69.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 276.32% | -264.23% | 2,186.02% | 104.16% | 64.50% |